Kang C - Search Results

1

Premature MicroRNA-Based Therapeutic: A "One-Two Punch" against Cancers.

Chen L, Huang K, Yi K, Huang Y, Tian X, Kang C. Chen L, et al. Among authors: kang c. Cancers (Basel). 2020 Dec 18;12(12):3831. doi: 10.3390/cancers12123831. Cancers (Basel). 2020. PMID: 33353171 Free PMC article. Review.

2

MicroRNA roles in beta-catenin pathway.

Huang K, Zhang JX, Han L, You YP, Jiang T, Pu PY, Kang CS. Huang K, et al. Mol Cancer. 2010 Sep 21;9:252. doi: 10.1186/1476-4598-9-252. Mol Cancer. 2010. PMID: 20858269 Free PMC article. Review.

3

Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription.

Han L, Yang Y, Yue X, Huang K, Liu X, Pu P, Jiang H, Yan W, Jiang T, Kang C. Han L, et al. Among authors: kang c. Brain Res. 2010 Dec 17;1366:9-17. doi: 10.1016/j.brainres.2010.09.097. Epub 2010 Oct 1. Brain Res. 2010. PMID: 20888802

4

High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression.

Zhang J, Huang K, Shi Z, Zou J, Wang Y, Jia Z, Zhang A, Han L, Yue X, Liu N, Jiang T, You Y, Pu P, Kang C. Zhang J, et al. Among authors: kang c. Neuro Oncol. 2011 Jun;13(6):600-9. doi: 10.1093/neuonc/nor034. Neuro Oncol. 2011. PMID: 21636708 Free PMC article.

5

β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.

Chen L, Huang K, Han L, Shi Z, Zhang K, Pu P, Jiang C, Kang C. Chen L, et al. Among authors: kang c. Int J Oncol. 2011 Oct;39(4):883-90. doi: 10.3892/ijo.2011.1104. Epub 2011 Jun 29. Int J Oncol. 2011. PMID: 21720709

6

Antitumor effect of aspirin in glioblastoma cells by modulation of β-catenin/T-cell factor-mediated transcriptional activity.

Lan F, Yue X, Han L, Yuan X, Shi Z, Huang K, Yang Y, Zou J, Zhang J, Jiang T, Pu P, Kang C. Lan F, et al. Among authors: kang c. J Neurosurg. 2011 Oct;115(4):780-8. doi: 10.3171/2011.5.JNS113. Epub 2011 Jul 1. J Neurosurg. 2011. PMID: 21721879

7

Nuclear translocation of β-catenin is essential for glioma cell survival.

Shi Z, Qian X, Li L, Zhang J, Zhu S, Zhu J, Chen L, Zhang K, Han L, Yu S, Pu P, Jiang T, Kang C. Shi Z, et al. Among authors: kang c. J Neuroimmune Pharmacol. 2012 Dec;7(4):892-903. doi: 10.1007/s11481-012-9354-3. Epub 2012 Mar 15. J Neuroimmune Pharmacol. 2012. PMID: 22415719

8

Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation.

Shi ZD, Qian XM, Liu CY, Han L, Zhang KL, Chen LY, Zhang JX, Pu PY, Yuan XB, Kang CS; Chinese Glioma Cooperative Group (CGCG). Shi ZD, et al. CNS Neurosci Ther. 2013 Feb;19(2):98-108. doi: 10.1111/cns.12041. Epub 2012 Dec 11. CNS Neurosci Ther. 2013. PMID: 23230963 Free PMC article.

9

AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.

Shi Z, Zhang J, Qian X, Han L, Zhang K, Chen L, Liu J, Ren Y, Yang M, Zhang A, Pu P, Kang C. Shi Z, et al. Among authors: kang c. Cancer Res. 2013 Sep 1;73(17):5519-31. doi: 10.1158/0008-5472.CAN-13-0280. Epub 2013 Jun 28. Cancer Res. 2013. PMID: 23811941

10

Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.

Zhang KL, Han L, Chen LY, Shi ZD, Yang M, Ren Y, Chen LC, Zhang JX, Pu PY, Kang CS. Zhang KL, et al. Cancer Lett. 2014 Jan 1;342(1):139-49. doi: 10.1016/j.canlet.2013.08.043. Epub 2013 Sep 3. Cancer Lett. 2014. PMID: 24012640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,236 results

Search Page